233 related articles for article (PubMed ID: 10755321)
1. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
Jiang HY; Hickey RJ; Abdel-Aziz W; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):320-8. PubMed ID: 10755321
[TBL] [Abstract][Full Text] [Related]
2. Ara-C affects formation of cancer cell DNA synthesome replication intermediates.
Abdel-Aziz W; Jiang HY; Hickey RJ; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):312-9. PubMed ID: 10755320
[TBL] [Abstract][Full Text] [Related]
3. Polymerization of the triphosphates of AraC, 2',2'-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase alpha and DNA primase.
Richardson KA; Vega TP; Richardson FC; Moore CL; Rohloff JC; Tomkinson B; Bendele RA; Kuchta RD
Biochem Pharmacol; 2004 Dec; 68(12):2337-46. PubMed ID: 15548380
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of the human cell DNA replication complex-associated DNA polymerases by the antimetabolite 1-beta-D-arabinofuranosylcytosine triphosphate (ara-CTP).
Han S; Hickey RJ; Tom TD; Wills PW; Syväoja JE; Malkas LH
Biochem Pharmacol; 2000 Aug; 60(3):403-11. PubMed ID: 10856436
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for topoisomerase I inhibition by nucleoside analogs.
Gmeiner WH; Yu S; Pon RT; Pourquier P; Pommier Y
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):653-8. PubMed ID: 14565246
[TBL] [Abstract][Full Text] [Related]
6. Action of 2',2'-difluorodeoxycytidine on DNA synthesis.
Huang P; Chubb S; Hertel LW; Grindey GB; Plunkett W
Cancer Res; 1991 Nov; 51(22):6110-7. PubMed ID: 1718594
[TBL] [Abstract][Full Text] [Related]
7. Interaction between DNA Polymerase lambda and anticancer nucleoside analogs.
Garcia-Diaz M; Murray MS; Kunkel TA; Chou KM
J Biol Chem; 2010 May; 285(22):16874-9. PubMed ID: 20348107
[TBL] [Abstract][Full Text] [Related]
8. Effect of DNA polymerase inhibitors on repair of gamma ray-induced DNA damage in proliferating (intact versus permeable) human fibroblasts: evidence for differences in the modes of action of aphidicolin and 1-beta-D-arabinofuranosylcytosine.
Mirzayans R; Enns L; Cubitt S; Karimian K; Radatus B; Paterson MC
Biochim Biophys Acta; 1994 Oct; 1227(1-2):92-100. PubMed ID: 7918688
[TBL] [Abstract][Full Text] [Related]
9. Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells.
Ross DD; Cuddy DP
Biochem Pharmacol; 1994 Oct; 48(8):1619-30. PubMed ID: 7980627
[TBL] [Abstract][Full Text] [Related]
10. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
Bergman AM; Munch-Petersen B; Jensen PB; Sehested M; Veerman G; Voorn DA; Smid K; Pinedo HM; Peters GJ
Biochem Pharmacol; 2001 Jun; 61(11):1401-8. PubMed ID: 11331076
[TBL] [Abstract][Full Text] [Related]
11. The human breast cell DNA synthesome: its purification from tumor tissue and cell culture.
Coll JM; Sekowski JW; Hickey RJ; Schnaper L; Yue W; Brodie AM; Uitto L; Syvaoja JE; Malkas LH
Oncol Res; 1996; 8(10-11):435-47. PubMed ID: 9114436
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1.
Prakasha Gowda AS; Polizzi JM; Eckert KA; Spratt TE
Biochemistry; 2010 Jun; 49(23):4833-40. PubMed ID: 20459144
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine.
Heinemann V; Hertel LW; Grindey GB; Plunkett W
Cancer Res; 1988 Jul; 48(14):4024-31. PubMed ID: 3383195
[TBL] [Abstract][Full Text] [Related]
14. 2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines.
Ruiz van Haperen VW; Veerman G; Vermorken JB; Peters GJ
Biochem Pharmacol; 1993 Aug; 46(4):762-6. PubMed ID: 8363650
[TBL] [Abstract][Full Text] [Related]
15. An in vitro model system that can differentiate the stages of DNA replication affected by anticancer agents.
Abdel-Aziz W; Hickey RJ; Malkas LH
Biochem Pharmacol; 2004 Jul; 68(1):11-21. PubMed ID: 15183113
[TBL] [Abstract][Full Text] [Related]
16. Interference of gemcitabine triphosphate with the measurements of deoxynucleotides using an optimized DNA polymerase elongation assay.
Smid K; Van Moorsel CJ; Noordhuis P; Voorn DA; Peters GJ
Int J Oncol; 2001 Jul; 19(1):157-62. PubMed ID: 11408937
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic and antiproliferative effects of gemcitabine and gemcitabine plus Ara-C on blast cells from patients with blast crisis chronic myeloproliferative disorders.
Santini V; Bernabei A; Gozzini A; Scappini B; Zoccolante A; D'Ippolito G; Figuccia M; Ferrini PR
Haematologica; 1997; 82(1):11-5. PubMed ID: 9172997
[TBL] [Abstract][Full Text] [Related]
18. Cellular elimination of 2',2'-difluorodeoxycytidine 5'-triphosphate: a mechanism of self-potentiation.
Heinemann V; Xu YZ; Chubb S; Sen A; Hertel LW; Grindey GB; Plunkett W
Cancer Res; 1992 Feb; 52(3):533-9. PubMed ID: 1732039
[TBL] [Abstract][Full Text] [Related]
19. Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines.
Galmarini CM; Warren G; Kohli E; Zeman A; Mitin A; Vinogradov SV
Mol Cancer Ther; 2008 Oct; 7(10):3373-80. PubMed ID: 18852140
[TBL] [Abstract][Full Text] [Related]
20. Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours.
Ruiz van Haperen VW; Veerman G; Boven E; Noordhuis P; Vermorken JB; Peters GJ
Biochem Pharmacol; 1994 Oct; 48(7):1327-39. PubMed ID: 7945430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
